Scientific Sessions 2025  /  Annual Lipid Update 2025  /  Targeting PCSK9 to lower LDL-C and CVD risk – A growing array of options
Logo

American Heart Association

  29
  0

Final ID:

Targeting PCSK9 to lower LDL-C and CVD risk – A growing array of options

  • Bohula, Erin  ( Brigham And Womens Hospital , Boston , Massachusetts , United States )
  • Odonoghue, Michelle  ( Brigham And Womens Hospital , Boston , Massachusetts , United States )
    • Author Disclosures:
    Erin Bohula: DO NOT have relevant financial relationships | michelle odonoghue: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Annual Lipid Update 2025

Sunday, 11/09/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Will apoCIII therapies tip the BALANCE towards targeting triglycerides?

Tsimikas Sotirios, Ballantyne Christie

Lp(a) may be little but has might: a review of recent lp(a) lowering trials

Bajaj Archna, Yeang Calvin

More abstracts from these authors:
The VESALIUS-CV Trial

Bohula Erin

Nutrition in the Cardiac Intensive Care Unit: Insights from a Survey of the Critical Care Cardiology Trials Network

Kochar Ajar, Campbell Greta, Bohula Erin, Berg David, Patel Siddharth, Baird-zars Vivian, Morrow David

You have to be authorized to contact abstract author. Please, Login
Not Available